The 20 Best Neonatal Severe Hyperparathyroidism Doctors Near Me in Ann Arbor, MI

Dr. Gauger is the William J. Fry Professor of Surgery in the Division of Endocrine Surgery. Dr. Gauger trained in General Surgery at the University of Michigan where he also completed fellowships in Extracorporeal Life Support and Surgical Critical Care. After graduation, he served as the T.S. Reeve International Fellow in Endocrine Surgery at the Royal North Shore Hospital in Sydney, Australia. He then returned to Michigan in 1999 to join the faculty in the Department of Surgery. Dr. Gauger specializes in the treatment of benign and malignant diseases of the thyroid, parathyroid, and adrenal glands in both adults and children. He also specializes in the treatment of endocrine tumors of the pancreas and intestines. He has a particular interest in the Multiple Endocrine Neoplasia Syndromes. Dr. Gauger is also a Professor of Learning Health Sciences and is deeply involved in graduate medical education issues. He serves as the Program Director for Surgery and leads the Norman W. Thompson Fellowship in Endocrine Surgery. He was also the founding Executive Director of the University of Michigan Clinical Simulation Center. Dr. Gauger is rated as a Distinguished provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Hyperparathyroidism, Thyroid Cancer, Parathyroid Hyperplasia, Parathyroidectomy, and Thyroidectomy. Dr. Gauger is board certified in Surgery.

Dr. Susan Pitt, MD, MPHS is an Associate Professor of Surgery and Director of the Endocrine Surgery Health Services Research Program in the Department of Surgery at Michigan Medicine. Dr. Pitt graduated Magna Cum Laude with a B.A. in psychology from Boston College in Chestnut Hill, MA. She received her medical degree from the Medical College of Wisconsin and a Masters degree in Population Health Science from Washington University in St. Louis which was supported by a scholarship from the BJC Healthcare Institute for Public Health. Dr. Pitt completed her general surgery residency at Washington University in St. Louis with Alpha Omega Alpha honors and was both the resident representative and administrative chief resident. During a two-year post-doctoral research fellowship at the University of Wisconsin, she was awarded a Ruth L. Kirschstein T32 training grant from the National Institutes of Health and the American College of Surgeons Resident Research Scholarship to study signaling pathways in neuroendocrine cancers. Following residency, Dr. Pitt completed an Endocrine Surgery Fellowship at Brigham & Women’s Hospital in Boston, MA before serving as an Assistant Professor of Surgery for six years at the University of Wisconsin in Madison, WI. Dr. Pitt joined the faculty of the University of Michigan in 2021.Dr. Pitt has received multiple awards for her clinical, research, and teaching efforts including the American Medical Women’s Association Exceptional Mentor Award in 2018 and an award from the University of Wisconsin-Madison Women in Science & Engineering Leadership Institute. She is a Fellow of the American College of Surgeons and active member of multiple organizations including the Association of Academic Surgery, Society of University Surgeons, American Association of Endocrine Surgeons, American Thyroid Association, Surgical Outcomes Club, Association of Women Surgeons, and Society for Medical Decision Making.Clinical Specialization: Dr. Pitt’s clinical interests include surgical diseases of the endocrine system including the thyroid, parathyroid, and adrenal glands. She has a particular interest and experience in the diagnosis and treatment of papillary thyroid cancer, functional adrenal tumors, and complex parathyroid disease. Dr. Pitt works closely with her endocrine oncology partners to provide excellent patient care and outcomes. Dr. Pitt is rated as a Distinguished provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Hyperparathyroidism, Papillary Thyroid Cancer, Thyroidectomy, and Parathyroidectomy. Dr. Pitt is board certified in Surgery.

Dr. Chun is a physician-scientist, who practices general endocrinology, including diabetes, thyroid diseases, and metabolic syndrome. His research is focused on the cellular and molecular mechanism of obesity, diabetes, and inflammatory and fibrotic tissue damages in endocrine disorders, such as Graves’ eye disease. Dr. Chun is rated as an Advanced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Hyperparathyroidism, Neonatal Severe Hyperparathyroidism, Osteitis Fibrosa, and Familial Isolated Hyperparathyroidism. Dr. Chun is board certified in Endocrinology, Diabetes & Metabolism and Internal Medicine.

Cristina Nieves is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Nieves is rated as an Advanced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Toxic Nodular Goiter, Thyroid Storm, Type 2 Diabetes (T2D), and Low Blood Sugar. Dr. Nieves is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Daniyeh Khurram is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Khurram is rated as an Advanced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Hyperparathyroidism, Neonatal Severe Hyperparathyroidism, Osteitis Fibrosa, Thrombectomy, and Endoscopy. Dr. Khurram is board certified in Endocrinology, Diabetes & Metabolism and Internal Medicine.

David Hughes is a General Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Hughes is rated as a Distinguished provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Familial Isolated Hyperparathyroidism, Parathyroid Hyperplasia, Osteitis Fibrosa, Parathyroidectomy, and Thymectomy.

Dr. Else’s primary appointment is with the Division of Metabolism, Endocrinology and Diabetes. He received his MD degree from the University of Hamburg, Germany. He pursued his clinical training at the University of Hamburg (Residency: Internal Medicine) and the University of Michigan (Residency: Internal Medicine, Fellowship: Endocrinology). His main research interests are the genetics of endocrine tumors. Dr. Else’s clinical practice focuses on the care for patients with benign and malignant endocrine tumors, particularly pheochromocytoma, adrenocortical tumors and neuroendocrine tumors as well as accompanying hormone excess syndromes (e.g Cushing syndrome, primary aldosteronism). Dr. Else has a particular interest in taking care of patients with hereditary syndromes that predispose to the development of endocrine tumors (e.g. Multiple Endocrine Neoplasia (MEN) type 1, MEN2A & MEN2B, Hereditary Paraganglioma Syndrome). He attends the Multidisciplinary Endocrine Oncology Clinic, where patients with tumors receive diagnostic procedures and treatment. In addition he is part of the Cancer Genetics Clinic, which evaluates patients for hereditary syndromes and also facilitates regular exams and surveillance for patients at risk for endocrine tumors. Dr. Else is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. He is also highly rated in 105 other conditions, according to our data. His clinical expertise encompasses Adrenal Cancer, Adrenocortical Carcinoma, Adrenal Gland Adenoma, Neuroendocrine Tumor, and Thyroidectomy. Dr. Else is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Zahrae Sandouk M.D., is a Clinical Assistant Professor, board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism and a graduate from Henry Ford Hospital and Cleveland Clinic who has an interest in Diabetes mellitus, Diabetes complications, Cystic Fibrosis related Diabetes, Pituitary disorders, Prolactinoma, Hypopituitarism, Thyroid disorders, Bone and calcium disorders, Adrenal and Osteoporosis. Also the medical director of the Endocrine Testing Unity at the University of Michigan where dynamic studies are performed and is also part of the Cystic Fibrosis multidisciplinary team. Dr. Sandouk is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. She is also highly rated in 39 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Adrenal Insufficiency Pediatric, Type 2 Diabetes (T2D), and Thyroid Nodule. Dr. Sandouk is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Dr. Gregory Clines is an Associate Professor of Internal Medicine in the Division of Metabolism, Endocrinology & Diabetes (MEND) at the University of Michigan. He received his MD and PhD degrees at the University of Texas Southwestern Medical Center at Dallas. He then completed internal medicine training at Duke University and an endocrinology fellowship at the University of Virginia. Before joining the University of Michigan in 2013, he was on the faculty at the University of Virginia and the University of Alabama at Birmingham.Dr. Clines has been studying and thinking about bone diseases for nearly 30 years. His basic science laboratory studies how novel factors such as hypoxia, androgens, endothelins, Wnt signaling, and other factors regulate the osteoblast-cancer cell synergy in bone metastasis. His other research interests include understanding how sex steroids regulate skeletal size and shape, and the development of novel imaging techniques to assess bone quality.His clinical interests include metabolic and genetic bone diseases as well as general endocrinology. Dr. Clines sees patients at the Metabolism, Endocrinology & Diabetes Clinic (Metabolic Bone Disease Clinic) and at the Ann Arbor Veterans Affairs Medical Center. Dr. Clines is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Osteoporosis, Paget's Disease of Bone, Postmenopausal Osteoporosis, Thyroidectomy, and Orchiectomy. Dr. Clines is board certified in Endocrinology, Diabetes & Metabolism.

Liselle Douyon is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Douyon is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Thyroid Nodule, and Juvenile Primary Osteoporosis.

Dr. Lynn Ang is currently a Clinical Associate Professor in the Metabolism, Endocrinology, and Diabetes Division, Internal Medicine Department at University of Michigan. Dr. Ang is one of the principle attending physicians for the Diabetes Transition Program. Dr. Ang’s clinical and research interests are in the fields of implementing optimal management of inpatient and outpatient hyperglycemia, creating protocols for inpatient hospital guidelines, identifying biomarkers to predict the development or progression of diabetic complications, detecting the earliest stages of complications to prevent progression of diseases, and developing sensitive diagnostic methods/treatment for those complications. Dr. Ang also serves as a Co-Director of Hospital Intensive Insulin Program. Dr. Ang has been actively involving in teaching internal medicine and podiatry residents, endocrinology fellows, and medical students in both ambulatory and inpatient clinical settings. She was a recipient of Goran Sundkvist Young Investigators Award for Clinical Science 2022. Dr. Ang is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Diabetic Neuropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young. Dr. Ang is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Nazanene H. Esfandiari, MD, is a Clinical Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes (MEND). Dr. Esfandiari received her medical degree from the University of Bordeaux in France, completed internal medicine residency in France and at UMASS Memorial Health Center in Massachusetts, and then completed fellowship in endocrinology at the University of Michigan. She joined the faculty at the University of Michigan in 2003. She was inducted into Clinical Excellence Society at the University of Michigan in 2014. She is the MEND Service Chief, Co-director of Hospital Intensive Insulin Program (HIIP) and Assistant Chief for the Inpatient Endocrine Consult.Dr. Esfandiari’s practice focuses on thyroid cancer, thyroid disorders, post bariatric care, and diabetes. She is also interested in medical education and is the Co-director of the Endocrine Sequence at the University of Michigan Medical School. In addition, Dr. Esfandiari has served in several national committees at the Endocrine Society and American Thyroid Association (ATA). Dr. Esfandiari is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, Gastric Bypass, and Thyroidectomy. Dr. Esfandiari is board certified in Endocrinology, Diabetes & Metabolism.

Dr. Kraftson specializes in treating patients with excess weight/obesity in addition to seeing patients with general endocrinologic conditions. He was inducted into the Clinical Excellence Society in 2021. He is the Director of the Weight Navigation Program & the Director of the Post Bariatric Endocrinology Clinic. Dr. Kraftson's research, focuses on gaining a better understanding of delivering effective care for individuals with obesity. In addition to these interests, Dr. Kraftson is actively involved in medical education and is the Associate Program Director for the M.E.N.D. Endocrinology Fellowship. Dr. Kraftson is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Obesity, Malnutrition, Type 2 Diabetes (T2D), Gastric Bypass, and Sleeve Gastrectomy. Dr. Kraftson is board certified in Endocrinology, Diabetes & Metabolism.

Maria Papaleontiou, MD, is an Associate Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes, and a Research Associate Professor at the Institute of Gerontology, at the University of Michigan. Prior to starting her internal medicine residency at Saint Peter's University Hospital in New Jersey, she spent several years conducting clinical research on aging at Weill Cornell Medical College in New York City. She completed her endocrinology fellowship at the University of Michigan, where she subsequently joined the faculty in 2013. She is a recipient of Fulbright and Howard Hughes Medical Institute scholarships. Her clinical practice focuses on thyroid diseases and thyroid cancer, as well as geriatric endocrinology.Dr. Papaleontiou is also a health services researcher in the field of thyroidology and aging. Her research focuses on evaluating the risks of thyroid hormone overtreatment and misuse in older adults, understanding the role of providers and patients in thyroid hormone use and misuse and how it relates to patient outcomes in the aging population, as well as the role of age and comorbidity in thyroid cancer decision-making. Her ultimate goal is to develop tools to tailor thyroid disease treatment to older adults by translating research findings into effective strategies and interventions to improve the care of older adults and reduce patient harm. She has received funding from the National Institute on Aging, the Claude D. Pepper Older American Independence Centers, the University of Michigan Biology of Cardiovascular Aging Core and the Elizabeth Caroline Crosby Research Award. She serves on multiple national committees including at the American Thyroid Association (ATA), the Endocrine Society, the American Association of Clinical Endocrinology and the North American Society for Interventional Thyroidology. She has served as Co-Chair for the ATA’s Annual Program Committee (2021-2022), Chair of the ATA’s Women in Thyroidology (2022-2023) and Vice-Chair for AACE's Thyroid Disease State Network (2022-2023). She is an Associate Editor for Endocrine Practice, and serves on the Editorial Boards for Thyroid and BMC Endocrine Disorders. Dr. Papaleontiou is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Thyroid Nodule, Hypothyroidism, Thyroidectomy, and Hormone Replacement Therapy (HRT). Dr. Papaleontiou is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Debbie Chen is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer, and Medullary Thyroid Carcinoma.

Nevin Ajluni, M.D., joined the team at the Division of Metabolism, Endocrinology & Diabetes (MEND) after serving a two-year endocrinology fellowship in the Division. She is a part of the care team in the MEND Weight Management Program, where she works with obese individuals by applying cutting-edge research findings and novel clinical strategies. She is an honors graduate of the Wayne State University School of Medicine and completed her internship and residency in internal medicine at the McGaw Medical Center of Northwestern University before coming to the University of Michigan. Dr. Ajluni is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Familial Partial Lipodystrophy, Type 2 Diabetes (T2D), and Congenital Generalized Lipodystrophy. Dr. Ajluni is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Merve Kutahyalioglu M.D., is a Clinical Assistant Professor in the Division of Metabolism, Endocrinology, and Diabetes. She completed her internal medicine internship and residency at the University of Texas Health Science Center, and endocrinology fellowship training at the Baylor College of Medicine. She is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism. Dr. Kutahyalioglu joined the faculty at the University of Michigan in 2021. She has an interest in general endocrinology. She is a part of the care team in the MEND Weight Management and MEND Post-Bariatric Surgery Care Program. Dr. Kutahyalioglu is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Malnutrition, Type 1 Diabetes (T1D), Obesity in Children, and Hyperparathyroidism. Dr. Kutahyalioglu is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Doctor Jennifer Wyckoff is a Clinical Professor of Internal Medicine in the Metabolism, Endocrinology and Diabetes/Podiatry Division. She received her MD degree from the University of South Florida in 1992 and completed her Internal Medicine Residency at the University of Utah in 1995. In addition, Dr. Wyckoff completed a fellowship in Endocrinology at the Brigham and Women's Hospital, Harvard Medical School, in 1999. Following that, she joined the faculty of the Joslin Diabetes Center, Harvard Medical School. While there, she practiced as part of the multidisciplinary Diabetes and Pregnancy program, a joint venture between the Joslin Diabetes Center and the Beth Israel Deaconess Hospital.In 2006, she joined the faculty at University of Michigan. Dr. Wyckoff serves as the Associate Clinical Chief for the Metabolism, Endocrinology and Diabetes/Podiatry Division and the Medical Director of the Adult Diabetes Education. Her clinical interests center on diabetes, with specific emphasis on diabetes and pregnancy, Type 1 diabetes and technology, patient education and cystic fibrosis related diabetes. Dr. Wyckoff is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Secondary Immunodeficiency (SID), and Gestational Diabetes. Dr. Wyckoff is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Preethi Gogineni is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. She has been practicing medicine for over 10 years. Dr. Gogineni is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Hyperparathyroidism, Type 1 Diabetes (T1D), Gestational Diabetes, and Osteoporosis.

Dr. Elif Oral is a professor in the Division of Metabolism, Endocrinology and Diabetes (MEND) at the University of Michigan. She completed her medical education in her home country of Turkey at the University of Istanbul. In 1996, she completed her residency in Internal Medicine at Sinai Hospital Detroit (Michigan). She then completed a fellowship in Endocrinology, Metabolism and Diabetes at the National Institute of Health, where she also chose to stay as a Senior Fellow under the mentorship of Drs SimeonTaylor and Phillip Gorden in in the Diabetes Branch of NIDDK.Since joining the University of Michigan in 2002 as an Assistant Professor of Medicine, along with her regular faculty responsibilities, Dr. Oral also completed a Masters of Science Degree in Clinical Research Design and Biostatistics at the School of Public Health. Her clinical interests are in insulin resistance, obesity, lipid disorders, and diabetes.Dr Oral's research focuses on the importance of adipocytes in human metabolism and adipocyte hormones such as leptin. She is best known for her work showing the remarkable efficacy of leptin in rare lipodystrophy syndromes. Metreleptin received approval by the FDA (2014) and EMA (2016) as a treatment for lipodystrophy owing to a large part to her original vision and work. These studies provided the basis for her current work with three big goals: identification of novel metabolic diseases, discovery of new disease mechanisms and finding treatments for patients afflicted with these disorders. In addition to her roles as physician, educator, and researcher, Dr Oral is also the director of two programs at MEND: Atypical Diabetes Program and Obesity and Metabolic Disorders Program. She directed the Post-Bariatric Surgery Care Program from 2012 to 2021 and continues to conduct research on the cohort of patients who had bariatric surgery performed in the Michigan Bariatric Surgery program. Dr. Oral is rated as an Experienced provider by MediFind in the treatment of Neonatal Severe Hyperparathyroidism. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Familial Partial Lipodystrophy, Congenital Generalized Lipodystrophy, Familial Hypertriglyceridemia, Gastric Bypass, and Sleeve Gastrectomy. Dr. Oral is board certified in Endocrinology, Diabetes & Metabolism.